- Commercial Platform
- Healthcare Partners
- News & Resources
- Schedule Demo
- Nasdaq: OPRX
25 April 2019
RARELY DO YOU FIND AN EMERGING GROWTH COMPANY that has taken a sea change in a major industry and turned it into a powerhouse of high-margin revenue and earnings. This is OptimizeRx (NASDAQ: OPRX)
In recent years, the U.S. healthcare system has become exceedingly complex and costly for everyone, and not only for patients, but also for doctors and hospitals. Even pharma is feeling the pinch.
Patients are facing an increasing cost burden due to expensive medications, and record-high deductibles and co-pays. The Kaiser Family Foundation reports that deductibles have risen 300 percent since 2006, while co-insurance costs have nearly doubled.
Combined with fewer generic drug options, this has created a ‘perfect storm’ that is undermining patient adherence to their doctor-prescribed medications. Patients simply cannot afford them, and doctors are increasingly frustrated.
Yet doctors want to help. A recent survey of 642 physicians by OptimizeRx revealed several key trends: Nearly all physicians believe they have a role to play in discussing the cost of health care with patients (91%) and are comfortable doing so (86%). Patients raise the issue of prescription drug costs with their doctors nearly 40% of the time.
Prescription drug costs are “very important” or “extremely important” to the vast majority of doctors (73%) and impact their prescribing decisions... Read more @Stock News Now- (Page 50-52)